Pharming Group N.V.
PHAR
$16.24
$0.030.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 376.50% | 15.11% | 90.22% | ||
| Total Depreciation and Amortization | -33.65% | 1,036.18% | -104.95% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1,484.43% | 128.33% | -3,268.06% | ||
| Change in Net Operating Assets | -196.45% | 179.12% | -785.97% | ||
| Cash from Operations | -4.22% | 173.69% | -72.89% | ||
| Capital Expenditure | 64.48% | -71.03% | -167.50% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -304.83% | -87.12% | 4,820.43% | ||
| Cash from Investing | -325.06% | -88.05% | 5,381.02% | ||
| Total Debt Issued | 100.00% | -100.25% | -- | ||
| Total Debt Repaid | -54.54% | 99.27% | -12,966.83% | ||
| Issuance of Common Stock | 9,004.35% | -99.11% | 191.63% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -1,212.26% | 63.00% | 75.31% | ||
| Cash from Financing | -53.80% | 94.94% | -1,045.45% | ||
| Foreign Exchange rate Adjustments | -454.82% | 125.98% | 196.46% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -142.29% | 384.63% | 51.77% | ||